{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T10:59:28Z","timestamp":1776164368575,"version":"3.50.1"},"reference-count":84,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:00:00Z","timestamp":1669334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>Tuberous Sclerosis (TS) is a rare genetic disorder manifesting with multiple benign tumors impacting the function of vital organs. In TS patients, dominant negative mutations in<jats:italic>TSC1<\/jats:italic>or<jats:italic>TSC2<\/jats:italic>increase mTORC1 activity. Increased mTORC1 activity drives tumor formation, but also severely impacts central nervous system function, resulting in infantile seizures, intractable epilepsy, and TS-associated neuropsychiatric disorders, including autism, attention deficits, intellectual disability, and mood disorders. More recently, TS has also been linked with frontotemporal dementia. In addition to TS, accumulating evidence implicates increased mTORC1 activity in the pathology of other neurodevelopmental and neurodegenerative disorders. Thus, TS provides a unique disease model to address whether developmental neural circuit abnormalities promote age-related neurodegeneration, while also providing insight into the therapeutic potential of mTORC1 inhibitors for both developing and degenerating neural circuits. In the following review, we explore the ability of both mouse and human brain organoid models to capture TS pathology, elucidate disease mechanisms, and shed light on how neurodevelopmental alterations may later contribute to age-related neurodegeneration.<\/jats:p>","DOI":"10.3389\/fgene.2022.997461","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T06:30:46Z","timestamp":1669357846000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Shared mechanisms of neural circuit disruption in tuberous sclerosis across lifespan: Bridging neurodevelopmental and neurodegenerative pathology"],"prefix":"10.3389","volume":"13","author":[{"given":"Karen","family":"Litwa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abg3897","article-title":"TSC1 loss increases risk for tauopathy by inducing tau acetylation and preventing tau clearance via chaperone-mediated autophagy","volume":"7","author":"Alquezar","year":"","journal-title":"Sci. Adv."},{"key":"B3","doi-asserted-by":"publisher","first-page":"E2895","DOI":"10.1073\/pnas.1321869111","article-title":"Activity-dependent dendritic spine neck changes are correlated with synaptic strength","volume":"111","author":"Araya","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B4","doi-asserted-by":"publisher","first-page":"7273","DOI":"10.3390\/ijms22147273","article-title":"Effects of mutations in TSC genes on neurodevelopment and synaptic transmission","volume":"22","author":"Bassetti","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.neuron.2013.03.017","article-title":"Excitatory\/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis","volume":"78","author":"Bateup","year":"2013","journal-title":"Neuron"},{"key":"B6","doi-asserted-by":"crossref","first-page":"P1.218","DOI":"10.1212\/WNL.84.14_supplement.P1.218","article-title":"Seizures and myoclonus in the early stages of frontotemporal dementia","volume":"84","author":"Beagle","year":"2015","journal-title":"Neurology"},{"key":"B7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1684\/j.1950-6945.2006.tb00167.x","article-title":"Basic developmental rules and their implications for epilepsy in the immature brain","volume":"8","author":"Ben-Ari","year":"2006","journal-title":"Epileptic Disord."},{"key":"B8","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrn920","article-title":"Excitatory actions of gaba during development: The nature of the nurture","volume":"3","author":"Ben-Ari","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3389\/fnins.2019.00304","article-title":"Toward a glutamate hypothesis of frontotemporal dementia","volume":"13","author":"Benussi","year":"2019","journal-title":"Front. Neurosci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1017\/S0033291715000264","article-title":"Intellectual abilities in tuberous sclerosis complex: Risk factors and correlates from the tuberous sclerosis 2000 study","volume":"45","author":"Bolton","year":"2015","journal-title":"Psychol. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/acel.12057","article-title":"mTOR regulates tau phosphorylation and degradation: implications for Alzheimer\u2019s disease and other tauopathies","volume":"12","author":"Caccamo","year":"2013","journal-title":"Aging Cell"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1002\/jnr.24503","article-title":"Developmental origins of cortical hyperexcitability in Huntington\u2019s disease: Review and new observations","volume":"97","author":"Cepeda","year":"2019","journal-title":"J. Neurosci. Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s13023-020-01488-4","article-title":"The TAND checklist: A useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1","volume":"15","author":"Cervi","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/j.1528-1167.2009.02474.x","article-title":"The natural history of epilepsy in tuberous sclerosis complex","volume":"51","author":"Chu-Shore","year":"2010","journal-title":"Epilepsia"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1002\/jnr.22392","article-title":"Synapse loss in dementias","volume":"88","author":"Clare","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3389\/fncel.2019.00048","article-title":"Reciprocal regulation of KCC2 trafficking and synaptic activity","volume":"13","author":"C\u00f4me","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.celrep.2016.02.090","article-title":"mTORC1 inhibition corrects neurodevelopmental and synaptic alterations in a human stem cell model of tuberous sclerosis","volume":"15","author":"Costa","year":"2016","journal-title":"Cell Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S1474-4422(15)00069-1","article-title":"Neurological and neuropsychiatric aspects of tuberous sclerosis complex","volume":"14","author":"Curatolo","year":"2015","journal-title":"Lancet. Neurol"},{"key":"B19","doi-asserted-by":"crossref","first-page":"E1618-E1626","DOI":"10.1073\/pnas.1716871115","article-title":"Restoring GABAergic inhibition rescues memory deficits in a Huntington's disease mouse model","volume":"115","author":"Dargaei","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B20","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1365-2788.2007.01030.x","article-title":"Attention deficits in tuberous sclerosis complex (TSC): Rethinking the pathways to the endstate","volume":"52","author":"de Vries","year":"2008","journal-title":"J. Intellect. Disabil. Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.pediatrneurol.2014.10.004","article-title":"Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND Checklist","volume":"52","author":"de Vries","year":"2015","journal-title":"Pediatr. Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/ajmg.c.31637","article-title":"A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)","volume":"178","author":"de Vries","year":"2018","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1016\/j.celrep.2019.04.034","article-title":"The ion transporter NKCC1 links cell volume to cell mass regulation by suppressing mTORC1","volume":"27","author":"Demian","year":"2019","journal-title":"Cell Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.ijdevneu.2013.02.008","article-title":"A circuitry and biochemical basis for tuberous sclerosis symptoms: From epilepsy to neurocognitive deficits","volume":"31","author":"Feliciano","year":"","journal-title":"Int. J. Dev. Neurosci."},{"key":"B25","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2020.00039","article-title":"The neurodevelopmental pathogenesis of tuberous sclerosis complex (TSC)","volume":"14","author":"Feliciano","year":"2020","journal-title":"Front. Neuroanat."},{"key":"B26","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.645233","article-title":"Astrocytic propagation of tau in the context of Alzheimer\u2019s disease","volume":"15","author":"Fleeman","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/ana.24523","article-title":"Everolimus for subependymal giant cell astrocytoma: 5-year final analysis","volume":"78","author":"Franz","year":"2015","journal-title":"Ann. Neurol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): A multicentre, randomised, placebo-controlled phase 3 trial","volume":"381","author":"Franz","year":"2013","journal-title":"Lancet (London, Engl."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","article-title":"Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): A phase 3, randomised, double-blind, placebo-controlled study","volume":"388","author":"French","year":"2016","journal-title":"Lancet (London, Engl."},{"key":"B30","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.jalz.2018.05.007","article-title":"Generation of a human induced pluripotent stem cell\u2013based model for tauopathies combining three microtubule-associated protein TAU mutations which displays several phenotypes linked to neurodegeneration","volume":"14","author":"Garc\u00eda-Le\u00f3n","year":"2018","journal-title":"Alzheimer\u2019s Dement."},{"key":"B31","doi-asserted-by":"publisher","first-page":"15474","DOI":"10.1073\/pnas.1107893108","article-title":"The neuronal K-Cl cotransporter KCC2 influences postsynaptic AMPA receptor content and lateral diffusion in dendritic spines","volume":"108","author":"Gauvain","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1038\/s41436-019-0562-6","article-title":"Low-level mosaicism in tuberous sclerosis complex: Prevalence, clinical features, and risk of disease transmission","volume":"21","author":"Giannikou","year":"2019","journal-title":"Genet. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e5251","DOI":"10.1371\/journal.pone.0005251","article-title":"The post-synaptic density of human postmortem brain tissues: An experimental study paradigm for neuropsychiatric illnesses","volume":"4","author":"Hahn","year":"","journal-title":"PLoS One"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1523\/JNEUROSCI.3191-12.2013","article-title":"Tau loss attenuates neuronal network hyperexcitability in mouse and Drosophila genetic models of epilepsy","volume":"33","author":"Holth","year":"2013","journal-title":"J. Neurosci."},{"key":"B35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuroscience.2012.05.003","article-title":"Rapamycin down-regulates KCC2 expression and increases seizure susceptibility to convulsants in immature rats","volume":"219","author":"Huang","year":"2012","journal-title":"Neuroscience"},{"key":"B36","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2174\/156720510793611592","article-title":"Tau in Alzheimer disease and related tauopathies","volume":"7","author":"Iqbal","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13023-016-0553-5","article-title":"TuberOus SClerosis registry to increase disease Awareness (TOSCA) \u2013 baseline data on 2093 patients","volume":"12","author":"Kingswood","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1002\/acn3.494","article-title":"Everolimus for treatment of tuberous sclerosis complex-associated neuropsychiatric disorders","volume":"4","author":"Krueger","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/ana.23960","article-title":"Everolimus treatment of refractory epilepsy in tuberous sclerosis complex","volume":"74","author":"Krueger","year":"2013","journal-title":"Ann. Neurol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.3390\/molecules27082440","article-title":"Beta-amyloid (A\u03b2(1-42)) increases the expression of NKCC1 in the mouse Hippocampus","volume":"27","author":"Lam","year":"2022","journal-title":"Molecules"},{"key":"B41","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"B42","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.neuron.2020.12.016","article-title":"Lowering Synaptogyrin-3 expression rescues Tau-induced memory defects and synaptic loss in the presence of microglial activation","volume":"109","author":"Largo-Barrientos","year":"2021","journal-title":"Neuron"},{"key":"B43","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1080\/14737175.2019.1635457","article-title":"Everolimus as adjunctive therapy for tuberous sclerosis complex-associated partial-onset seizures","volume":"19","author":"Lechuga","year":"2019","journal-title":"Expert Rev. Neurother."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.neuron.2007.10.039","article-title":"KCC2 interacts with the dendritic cytoskeleton to promote spine development","volume":"56","author":"Li","year":"2007","journal-title":"Neuron"},{"key":"B45","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.neuron.2014.09.034","article-title":"The neurology of mTOR","volume":"84","author":"Lipton","year":"2014","journal-title":"Neuron"},{"key":"B46","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40478-022-01330-x","article-title":"Tuberous sclerosis complex is a novel, amyloid-independent tauopathy associated with elevated phosphorylated 3R\/4R tau aggregation","volume":"10","author":"Liu","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"key":"B48","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1001\/jamaneurol.2019.4284","article-title":"Association of cognitive and behavioral features between adults with tuberous sclerosis and frontotemporal dementia","volume":"77","author":"Liu","year":"","journal-title":"JAMA Neurol."},{"key":"B49","article-title":"Role of NKCC1 and KCC2 in epilepsy: From expression to function [internet]","volume":"10","author":"Liu","year":"","journal-title":"Front. Neurology"},{"key":"B50","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neuropharm.2006.07.027","article-title":"LTP consolidation: Substrates, explanatory power, and functional significance","volume":"52","author":"Lynch","year":"2007","journal-title":"Neuropharmacol."},{"key":"B51","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1523\/JNEUROSCI.0244-14.2015","article-title":"Altered sensory experience exacerbates stable dendritic spine and synapse loss in a mouse model of huntington's disease","volume":"35","author":"Murmu","year":"2015","journal-title":"J. Neurosci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"7047","DOI":"10.1038\/s41380-021-01104-2","article-title":"Altered network and rescue of human neurons derived from individuals with early-onset genetic epilepsy","volume":"26","author":"Negraes","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"B53","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1083\/jcb.201504046","article-title":"ROCK1 and 2 differentially regulate actomyosin organization to drive cell and synaptic polarity","volume":"210","author":"Newell-Litwa","year":"2015","journal-title":"J. Cell Biol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00401-017-1764-0","article-title":"Linking tuberous sclerosis complex, excessive mTOR signaling, and age-related neurodegeneration: A new association between TSC1 mutation and frontotemporal dementia","volume":"134","author":"Olney","year":"2017","journal-title":"Acta Neuropathol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"951","DOI":"10.2147\/TCRM.S145630","article-title":"Everolimus for the treatment of refractory seizures associated with tuberous sclerosis complex (TSC): Current perspectives","volume":"15","author":"Overwater","year":"2019","journal-title":"Ther. Clin. Risk Manag."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062459","article-title":"Rapamycin attenuates the progression of tau pathology in P301S tau transgenic mice","volume":"8","author":"Ozcelik","year":"2013","journal-title":"PLoS One"},{"key":"B57","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nn.2741","article-title":"Dendritic spine pathology in neuropsychiatric disorders","volume":"14","author":"Penzes","year":"2011","journal-title":"Nat. Neurosci."},{"key":"B59","first-page":"30","article-title":"Neuroscience letters","volume":"601","author":"Phillips","year":"2014","journal-title":"Dendritic spine dysgenesis autism Relat. Disord."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12959","article-title":"Emerging role of AMPA receptor subunit GluA1 in synaptic plasticity: Implications for Alzheimer\u2019s disease","volume":"54","author":"Qu","year":"2021","journal-title":"Cell Prolif."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neubiorev.2018.12.014","article-title":"Upregulated levels and pathological aggregation of abnormally phosphorylated Tau-protein in children with neurodevelopmental disorders","volume":"98","author":"Rankovic","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B62","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.nbd.2016.07.014","article-title":"Functional aspects of early brain development are preserved in tuberous sclerosis complex (TSC) epileptogenic lesions","volume":"95","author":"Ruffolo","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.1093\/cercor\/bhv218","article-title":"Developmental expression patterns of KCC2 and functionally associated molecules in the human brain","volume":"26","author":"Sedmak","year":"2016","journal-title":"Cereb. Cortex"},{"key":"B64","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2010.00011","article-title":"GABAergic control of neurite outgrowth and remodeling during development and adult neurogenesis: General rules and differences in diverse systems [internet]","volume":"4","author":"Sernagor","year":"2010","journal-title":"Front. Cell. Neurosci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/j.1469-8749.1992.tb11515.x","article-title":"Seizures and intellectual disability associated with tuberous sclerosis complex in the west of scotland","volume":"34","author":"Shepherd","year":"1992","journal-title":"Dev. Med. Child. Neurol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0092-8674(01)00321-X","article-title":"Subunit-specific rules governing AMPA receptor trafficking to synapses in hippocampal pyramidal neurons","volume":"105","author":"Shi","year":"2001","journal-title":"Cell"},{"key":"B67","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.1038\/s41467-020-16984-1","article-title":"Prolonged tau clearance and stress vulnerability rescue by pharmacological activation of autophagy in tauopathy neurons","volume":"11","author":"Silva","year":"2020","journal-title":"Nat. Commun."},{"key":"B68","doi-asserted-by":"crossref","first-page":"8291","DOI":"10.1523\/JNEUROSCI.5205-14.2015","article-title":"Selective inhibition of KCC2 leads to hyperexcitability and epileptiform discharges in hippocampal slices and in vivo","volume":"35","author":"Sivakumaran","year":"2015","journal-title":"J. Neurosci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3389\/fncel.2020.592607","article-title":"Synaptic loss in alzheimer's disease: Mechanistic insights provided by two-photon in vivo imaging of transgenic mouse models","volume":"14","author":"Subramanian","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/ana.22696","article-title":"Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia","volume":"71","author":"Talos","year":"2012","journal-title":"Ann. Neurol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"E240","DOI":"10.3390\/cells9010240","article-title":"The expanding therapeutic potential of neuronal KCC2","volume":"9","author":"Tang","year":"2020","journal-title":"Cells"},{"key":"B72","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.neuron.2014.07.040","article-title":"Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits","volume":"83","author":"Tang","year":"2014","journal-title":"Neuron"},{"key":"B73","doi-asserted-by":"crossref","first-page":"eaau0164","DOI":"10.1126\/scitranslmed.aau0164","article-title":"Pharmacological enhancement of KCC2 gene expression exerts therapeutic effects on human Rett syndrome neurons and Mecp2 mutant mice","volume":"11","author":"Tang","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"B74","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1073\/pnas.1524013113","article-title":"KCC2 rescues functional deficits in human neurons derived from patients with Rett syndrome","volume":"113","author":"Tang","year":"2016","journal-title":"Proc. Natl. Acad. Sci"},{"key":"B75","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41398-022-02024-7","article-title":"Neuronal hyperexcitability in Alzheimer\u2019s disease: What are the drivers behind this aberrant phenotype?","volume":"12","author":"Targa Dias Anastacio","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"B76","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/npp.2009.115","article-title":"Normal development of brain circuits","volume":"35","author":"Tau","year":"2010","journal-title":"Neuropsychopharmacol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1038\/nn1566","article-title":"Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2","volume":"8","author":"Tavazoie","year":"2005","journal-title":"Nat. Neurosci."},{"key":"B78","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3389\/fpsyt.2016.00101","article-title":"Dendritic spines as tunable regulators of synaptic signals","volume":"7","author":"T\u00f8nnesen","year":"2016","journal-title":"Front. Psychiatry"},{"key":"B79","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pediatrneurol.2014.10.024","article-title":"Long-term everolimus treatment in individuals with tuberous sclerosis complex: A review of the current literature","volume":"53","author":"Tran","year":"2015","journal-title":"Pediatr. Neurol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1086\/302412","article-title":"High rate of mosaicism in tuberous sclerosis complex","volume":"64","author":"Verhoef","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"B81","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.tins.2021.01.004","article-title":"The multifaceted roles of KCC2 in cortical development","volume":"44","author":"Virtanen","year":"2021","journal-title":"Trends Neurosci."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1002\/aur.2590","article-title":"The prevalence and incidence of early-onset dementia among adults with autism spectrum disorder","volume":"14","author":"Vivanti","year":"2021","journal-title":"Autism Res."},{"key":"B83","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.molcel.2017.09.020","article-title":"mTORC1 phosphorylates acetyltransferase p300 to regulate autophagy and lipogenesis","volume":"68","author":"Wan","year":"2017","journal-title":"Mol. Cell"},{"key":"B84","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1091\/mbc.E18-04-0222","article-title":"Stem cell models of human synapse development and degeneration","volume":"29","author":"Wilson","year":"2018","journal-title":"Mol. Biol. Cell"},{"key":"B85","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1097\/01.jnen.0000228202.35163.c4","article-title":"Synaptic vulnerability in neurodegenerative disease","volume":"65","author":"Wishart","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"5155","DOI":"10.1038\/srep05155","article-title":"Activation of Rheb, but not of mTORC1, impairs spine synapse morphogenesis in tuberous sclerosis complex","volume":"4","author":"Yasuda","year":"2014","journal-title":"Sci. Rep."},{"key":"B87","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41591-018-0336-8","article-title":"ApoE attenuates unresolvable inflammation by complex formation with activated C1q","volume":"25","author":"Yin","year":"","journal-title":"Nat. Med."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.997461\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T14:42:53Z","timestamp":1728484973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.997461\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,25]]},"references-count":84,"alternative-id":["10.3389\/fgene.2022.997461"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2022.997461","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,25]]},"article-number":"997461"}}